Everything about Let's Go: effects, typical THC, lineage, and terpenes — plus hands-on product reviews and bud photos from Toker's Guide's DMV experts. < Back Let's Go Strain Review Type Hybrid THC % 18% Dominant Terpene Energy NA Unknown Overview Let's Go is an energizing hybrid marijuana strain favored for its refreshing citrus notes and functional high. Popular in legal markets for its ability to provide a mental spark without overwhelming sedation, it serves as a versatile choice for both recreational and medicinal users seeking a daytime boost. Effects Let's Go is an uplifting and clear-headed hybrid strain that induces a sense of euphoria and increased focus, making it ideal for high-energy activities like creative tasks, morning routines, or social engagement. It provides a noticeable mental spark and energy boost while remaining balanced enough to avoid significant anxiety. This strain is particularly effective for those seeking a daytime boost to stay productive and positive, and its anti-stress properties make it suitable for managing daily tension. The terpene profile is led by limonene, which provides its signature citrus scent and mood-enhancing effects, followed by myrcene, which adds an earthy touch and relaxing physical undertones, and caryophyllene, which contributes a peppery spice and supports its anti-stress benefits. Positive Effects Side Effects Common Uses Relaxed 0% Happy 0% Euphoric 0% Uplifted 0% Talkative 0% Creative 0% Energetic 0% Focused 0% Giggly 0% Tingly 0% Hungry 0% Sleepy 0% Unknown Dry Mouth 0% Dry Eyes 0% Dizzy 0% Paranoid 0% Anxious 0% Hungry 0% Tingly 0% Sleepy 0% Appearance The buds of Let's Go are typically elongated and bright forest green, accented by a dense layer of curly orange pistils. A fine coating of milky white trichomes gives the flower a frosted appearance and a slightly tacky feel. Aroma This strain is defined by a sharp, pungent fragrance dominated by zesty lemon and sweet citrus. Underneath the initial fruitiness, there are subtle notes of earthy pine and a faint chemical or diesel-like sharpness that becomes more apparent when the buds are broken apart. Flavor On the inhale, Let's Go delivers a crisp taste of tart lemon and sugary citrus peel. The exhale is smoother, leaving a lingering aftertaste of herbal tea, spice, and a woody finish that grounds the brighter fruit flavors. Lineage While specific breeder secrets are often kept close, Let's Go is widely recognized as a cross between the flavor-packed Lemon Tree and the classic, high-energy Sour Diesel. This heritage ensures a profile rich in both citrus zest and cerebral potency. Terpene Profile - Limonene: The primary terpene, providing the signature lemon scent and mood-enhancing effects. - Myrcene: Adds a touch of herbal earthiness and contributes to the strain's relaxing physical undertones. - Caryophyllene: Offers a subtle peppery spice and supports the strain's anti-stress properties.Effects Let's Go is celebrated for its uplifting and clear-headed effects. It typically induces a sense of euphoria and increased focus, making it ideal for creative tasks, morning routines, or social engagement. While it provides a noticeable energy boost, it is generally balanced enough to avoid the anxiety sometimes associated with pure sativas. Cultivation Preferences This strain is considered moderately easy to grow, though it requires attention to its height as it tends to stretch during flowering. - Flowering Time: Usually takes between 8 and 9 weeks to reach maturity. - Yield: Produces a respectable harvest of dense, aromatic buds when grown in optimal conditions. - Climate: Prefers a warm, dry environment with plenty of light and consistent airflow to prevent moisture buildup in its dense flower clusters.Origin Let's Go originated in the United States, gaining prominence through major commercial cultivators in the Illinois and California markets who sought to perfect a citrus-forward, sativa-leaning hybrid for mass appeal. Seed Suppliers Authentic seeds for Let's Go can be difficult to find as it is often held as a proprietary cut by large-scale producers like Cresco (High Supply). However, similar genetics can be sourced through reputable seed banks by searching for Lemon Tree and Sour Diesel hybrids. Conclusion Let's Go is a premier choice for cannabis enthusiasts who value flavor and functionality. Its bright terpene profile and motivating effects make it a reliable companion for staying productive and positive throughout the day. Previous Next

Everything about Allen Iverson OG: effects, typical THC, lineage, and terpenes — plus hands-on product reviews and bud photos from Toker's Guide's DMV experts. < Back Allen Iverson OG Strain Review Type Indica THC % 23% Dominant Terpene Energy NA Happy, Relaxed Overview Allen Iverson OG, also known as Iverson OG, is a heavy-hitting indica strain developed by the California-based cultivators Good as Gold. Specifically engineered for consumers with an exceptionally high THC tolerance, this strain is celebrated for its profound physical sedation and soaring cerebral effects. Effects Allen Iverson OG is a heavy-hitting indica strain that delivers a potent one-two punch, beginning with a powerful euphoric rush that launches the mind into a dreamy, cosmic state before transitioning into deep physical tranquilization. This strain is specifically designed for consumers with high THC tolerance and is highly effective for managing chronic pain, severe insomnia, and stress. Its terpene profile is dominated by myrcene, which provides significant sedative "couch-lock" effects and an herbal aroma; limonene, which elevates the mood with a subtle citrus brightness; and caryophyllene, which contributes spicy, fuel-like notes and potential anti-inflammatory benefits. Due to its intense paralyzing physical effects and ability to provide profound sedation, Allen Iverson OG is best suited for low-energy activities and nighttime use. Positive Effects Side Effects Common Uses Relaxed 50% Happy 100% Euphoric 0% Uplifted 0% Talkative 0% Creative 0% Energetic 0% Focused 50% Giggly 0% Tingly 0% Hungry 50% Sleepy 50% stress, depression, anxiety, insomnia, lack_of_appetite Dry Mouth 0% Dry Eyes 0% Dizzy 0% Paranoid 0% Anxious 0% Hungry 50% Tingly 0% Sleepy 50% Appearance The buds of Allen Iverson OG are typically dense and chunky, displaying a deep forest green hue with occasional purple undertones. They are coated in a thick, sticky layer of crystalline trichomes and accented by thin, fiery orange pistils, reflecting its high potency. Aroma The aromatic profile is pungent and complex. It lead with heavy notes of sour fuel and diesel, which are balanced by deep, earthy undertones of damp wood and sweet pine. Flavor On the palate, this strain delivers a rich blend of sweet pine and sandalwood. The exhale is notably sharp, leaving a lingering taste of sour gas and spicy earth that appeals to connoisseurs of classic "gas" profiles. Lineage While the exact genetic cross is a closely guarded secret by Good as Gold, Allen Iverson OG is believed to be a premium phenotype or cross involving specialized OG Kush lineages, resulting in its signature heavy indica characteristics. Terpene Profile - Myrcene: The dominant terpene, contributing to the strain's herbal aroma and heavy sedative "couch-lock" effects. - Limonene: Adds a subtle citrus brightness to the scent and helps elevate the mood. - Caryophyllene: Provides the spicy, fuel-like notes and potential anti-inflammatory benefits.Effects This strain is renowned for its "one-two punch" effect. It begins with a powerful euphoric rush that launches the mind into a dreamy, cosmic state, followed quickly by a heavy physical tranquilization. It is highly effective for managing chronic pain, severe insomnia, and stress. Cultivation Preferences Allen Iverson OG is typically grown indoors to maintain the strict environmental controls required for its "Good as Gold" quality. - Flowering Time: Approximately 8 to 9 weeks. - Environment: Prefers a controlled Mediterranean climate with low humidity during the late flowering stage to protect its dense buds. - Yield: Moderate to high, rewarding growers who use optimized nutrient cycles.Origin The strain originated in California, USA, where it was bred and trademarked by the cultivation group Good as Gold. Seed Suppliers Authentic Allen Iverson OG seeds or clones are difficult to source as the genetics are maintained exclusively by Good as Gold. Enthusiasts may find similar OG-heavy hybrids through specialty California nurseries or boutique seed banks like Neptune Seed Bank. Conclusion Allen Iverson OG stands as a premier choice for experienced users seeking a true "knockout" strain. Its combination of intense fuel flavors and paralyzing physical effects makes it a standout tribute to its legendary namesake, providing a high-performance experience for the most demanding cannabis enthusiasts. Previous Next

Virginia lawmakers approved legislation to establish a regulated retail market for adult-use cannabis, with sales set to begin January 1, 2027, pending Governor Abigail Spanberger's signature. The bill creates a statewide licensing and tax framework, increases possession limits to 2.5 ounces, and includes equity provisions such as microbusiness licenses and a reinvestment fund for communities disproportionately affected by past drug enforcement. < Back Virginia Lawmakers Celebrate Passage of Recreational Cannabis Sales Bill Mar 18, 2026 Source: Marijuana Moment Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Virginia is finally closing the gap between legal possession and legal sales. After years of legislative limbo and vetoes, state lawmakers just passed a major bill to launch a regulated adult-use cannabis market. If Governor Spanberger signs it as expected, retail sales will officially kick off on January 1, 2027. The plan is solid: it sets up a 350-license cap, a statewide tax structure (around 12-16% total), and—best of all for tokers—it bumps the legal possession limit from one ounce up to 2.5 ounces. It also smartly avoids a "patchwork" system by preventing local opt-outs, ensuring consistent access across the Commonwealth. Plus, there’s a real focus on equity, with microbusiness licenses and reinvestment funds for communities hit hardest by the War on Drugs. This is a massive win for the community because it replaces the sketchy "gray market" with lab-tested, regulated products. For regular users, this means more variety, better safety standards, and the peace of mind that comes with a fully legal, professional industry. < Previous Next > Recent Reviews Bomb Popz Infused Pre-Roll - Fade Co. (Story Dispensary, Waldorf, MD) This Bomb Popz infused pre-roll starts winning before you even open the tube. The name alone is a hit of pure nostalgia. You remember the popsicle - red, white, and blue, chased down the block on a sweltering afternoon, guaranteed to turn your tongue three colors. It made an ordinary summer day feel like a holiday. Fade Co bottled that carefree energy and rolled it into a diamond-infused pre-roll. And the potency backs up the fun: premium indoor flower boosted with THCA diamo Torrone #2 by Savvy - gLeaf (Rockville, Maryland) Cultivated by Savvy and available at gLeaf Dispensary in Rockville, this lovely batch of Torrone #2 is an intriguing introduction to mode... Jokerz by Alt Sol - Green Theory DC This batch of Jokerz, cultivated by Alt Sol and currently available at Green Theory dispensary in Washington DC, is an indica-dominant st... 1 2 3 4 5

D.C. cannabis board extends temporary medical patient cards to 90 days and removes photo requirements to address application backlogs. < Back D.C. cannabis regulators extend temporary patient cards amid surge in applications Mar 15, 2026 Source: Editorial Staff Outlaw Report Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The D.C. cannabis board adopted a third emergency rule extending temporary medical cannabis patient cards from 30 to 90 days and removing the passport photo requirement, citing a sharp increase in patient applications that has slowed processing times. Source < Previous Next > Recent Reviews Bomb Popz Infused Pre-Roll - Fade Co. (Story Dispensary, Waldorf, MD) This Bomb Popz infused pre-roll starts winning before you even open the tube. The name alone is a hit of pure nostalgia. You remember the popsicle - red, white, and blue, chased down the block on a sweltering afternoon, guaranteed to turn your tongue three colors. It made an ordinary summer day feel like a holiday. Fade Co bottled that carefree energy and rolled it into a diamond-infused pre-roll. And the potency backs up the fun: premium indoor flower boosted with THCA diamo Torrone #2 by Savvy - gLeaf (Rockville, Maryland) Cultivated by Savvy and available at gLeaf Dispensary in Rockville, this lovely batch of Torrone #2 is an intriguing introduction to mode... Jokerz by Alt Sol - Green Theory DC This batch of Jokerz, cultivated by Alt Sol and currently available at Green Theory dispensary in Washington DC, is an indica-dominant st... 1 2 3 4 5

The Cannabis industry is on the cusp of a monumental shift with the potential rescheduling of Cannabis from Schedule I to Schedule III. This shift could unleash growth, investment, and opportunity, but it also means a new ballgame for accounting and tax. The benefits of rescheduling include increased participation from banks, access to capital markets, and interstate commerce. However, challenges will remain, including compliance and regulatory complexities. Accountants and financial professionals will play a critical role in this new landscape. Investors will expect solid financial controls, compliance with regulations, and clear growth strategies. The elimination of 280E could have a massive impact on valuations. The regulatory landscape will be complex, with continued state-level regulations and increased federal involvement. Accountants will need to stay updated with rapidly changing regulations. < Back Rescheduling Cannabis: How It Will Shake Up Accounting & Tax Jun 15, 2024 Source: Dope CFO Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link The Cannabis industry is on the cusp of a monumental shift that's about to rock the accounting and tax world. As a CPA with nearly a decade of experience in this niche, I've watched this industry explode from the ground up. We've gone from zero to a $33 billion legal market in 2023, with support for legalization at an all-time high. But hold onto your calculators, folks – what's coming next is going to make the past few years look like a warm-up lap. In April 2024, the DEA dropped a bombshell: they're considering rescheduling Cannabis from Schedule I to Schedule III. This isn't just another regulatory tweak; it's a seismic shift that could unleash a tidal wave of growth, investment, and opportunity. But it also means a whole new ballgame for accounting and tax in the Cannabis world. In this guide, we will provide an overview of how Cannabis rescheduling will impact accounting and tax, including: - The impact Cannabis rescheduling will have on valuations - How accounting and tax will change when Cannabis is rescheduled - What Cannabis accountants can do to prepare for Cannabis rescheduling - How Cannabis accountants can provide added value in the changing landscape If you're an accountant, investor, or Cannabis business owner, you need to be ready for what's coming. In this guide, I'm going to break down exactly how this rescheduling could shake up the industry, what it means for your bottom line, and how you can position yourself to ride this green wave to success. Let's dive in. *How Likely Is Cannabis Rescheduling?* One of the first questions we always get is, “how likely is Cannabis rescheduling or legalization?” People worry there is still a social stigma attached to marijuana and that it will impact not only the potential for rescheduling and legalization but also their potential for success in the Cannabis industry. According to an article published by Bloomberg, attitudes on Cannabis have shifted significantly in the last 50-60 years. Nearly 70% of all American adults now support full legalization. That is up from around 10% in 1969. (Source: Gallup) There is also bipartisan support for Cannabis legalization. Both red states and blue states support Cannabis legalization. For example, Cannabis is fully legal in Oklahoma, a traditionally red state, and Oregon, a historically blue state. (Source: mjbizdaily.com) You can poll any group you want - Republicans, Democrats, Independents - and you’ll find that a majority of adults support legalization. We have many examples of this across the United States. 24 out of 50 states now have full Cannabis legalization; we’ve seen that go from 0 to 24 in 10 years, and we expect that number to rise as we get closer to the 2024 election. All of that is to say, the industry and attitudes are changing. It will most likely begin with the DEA approving the rescheduling of Cannabis. Let’s look at what that means. *Understanding the Controlled Substances Act* The Controlled Substances Act established a federal drug policy that regulates the manufacture, importation, possession, use, and distribution of certain substances. The legislation created five schedules, or classifications, along with qualifications for a substance to be included in each. We’ll focus on Schedule 1, where Cannabis is currently scheduled, and Schedule III, the new proposed schedule for Cannabis. Schedule I is the highest and harshest schedule for a substance under the act. For a substance to be classified as Schedule I, it is said to have no medical use and high potential for both abuse and addiction. Other examples of substances classified as Schedule I include ecstasy, methamphetamine, heroin, and LSD. Something to note is that even drugs like fentanyl and oxycodone, which are responsible for tens of thousands of deaths annually, currently fall under Schedule II. Schedule III, the new proposed classification for Cannabis, is much milder. The substances in this classification have medical uses and while they still possess the potential for abuse and addiction, the risk is much lower. Other examples of substances in this classification include Tylenol, codeine, testosterone, and ketamine. Some of these are available over the counter while others are regularly prescribed by doctors. The DEA has recommended that Cannabis be moved from Schedule I to Schedule III. The reclassification would lead to a cascade of state and federal-level changes, and will completely change the market. *The Rescheduling Process* In October 2022, the Biden Administration launched an investigation into Cannabis being on Schedule I. The Health and Human Services (HHS) department recommended Cannabis be moved to Schedule III, and the FDA agreed. Now rescheduling is awaiting approval from the DEA. We’re cautiously optimistic as the DEA typically follows the recommendations from the HHS department. For now, things are looking green for the prospect of rescheduling at the very least. The Biden Administration is doing everything it can to gather votes and many industry experts, including us here at DOPE CFO, believe rescheduling will happen sooner rather than later. Let’s look at the benefits of rescheduling as well as some of the potential challenges that could arise. *Benefits and Challenges of Rescheduling* There are benefits and challenges that will come from rescheduling, We’ll start with the benefits. *Banking: from cash-only to full financial integration* The current banking situation for Cannabis businesses is, to put it mildly, challenging. Due to federal prohibition, most traditional banks have shied away from serving Cannabis clients, fearing potential legal repercussions. This has created a host of issues that have hampered the industry's growth and operational efficiency. Currently, many Cannabis businesses operate primarily in cash, which presents significant security risks and operational headaches. Imagine trying to manage payroll, pay taxes, or handle large transactions entirely in cash. It's not just inconvenient; it's dangerous and inefficient. Some Cannabis businesses have managed to secure limited banking services through state-chartered banks or credit unions willing to take on the risk and compliance burden. However, these services often come with hefty fees and restrictions, making them less than ideal for growing businesses. The lack of banking access has broader implications beyond day-to-day operations. Without bank accounts, Cannabis businesses struggle to build credit histories, making it nearly impossible to secure loans or lines of credit for expansion. This has forced many to rely on private investors or alternative funding sources, often at much higher interest rates than traditional business loans. Rescheduling Cannabis to Schedule III would fundamentally alter this landscape. While it wouldn't automatically solve all banking issues overnight, it would significantly reduce the perceived risk for financial institutions. Here's what we might expect: - *Increased Participation from Banks: *More banks, including larger national institutions, would likely begin offering services to Cannabis businesses. This increased competition could lead to better service offerings and reduced fees. - *Normalization of Financial Services:* Cannabis businesses could expect access to the full suite of financial services other industries take for granted. This includes business checking and savings accounts, merchant services for credit card processing, and payroll services. - *Electronic Payment Solutions:* With banking restrictions eased, we could see a proliferation of electronic payment solutions tailored for the Cannabis industry. This would reduce cash handling, improve security, and enhance the customer experience. - *Access to Capital Markets:* Improved banking relationships could pave the way for Cannabis businesses to access capital markets more easily. This could include everything from business loans and lines of credit to the ability to issue corporate bonds. - *Reduced Compliance Burden:* While compliance will always be a crucial aspect of Cannabis banking, rescheduling could simplify the reporting requirements for banks. This could make Cannabis accounts less costly to maintain, potentially reducing fees for businesses. - *Interstate Banking: *As the industry moves towards interstate commerce, having banking partners that can operate across state lines will become crucial. Rescheduling could make it easier for national banks to serve multi-state operators. However, it's important to note that challenges will remain. Banks will still need to comply with anti-money laundering laws and know-your-customer regulations. Cannabis businesses will need to maintain meticulous records and demonstrate full regulatory compliance to maintain their banking relationships. As accountants and financial professionals, our role in this new banking landscape will be critical. We'll need to help our clients navigate the transition from cash-based operations to full banking integration, ensuring they have the systems and controls in place to meet banks' requirements. Additionally, we'll play a key role in helping Cannabis businesses leverage their new banking relationships to fuel growth and improve operational efficiency. The shift in banking access represents a monumental change for the Cannabis industry. It's not just about having a place to deposit cash; it's about gaining access to the full spectrum of financial tools that can help these businesses scale, innovate, and compete in an increasingly sophisticated market. *Bankruptcy Protection: A Crucial Safety Net* Currently, Cannabis businesses operate in a precarious financial environment due to their inability to access bankruptcy protection. This is a direct result of Cannabis being classified as a Schedule I substance at the federal level. Let me illustrate why this is so significant. I've seen this impact firsthand. One of the first Cannabis farms I worked with went under, and the consequences were dire. Without the option of bankruptcy protection, there was no structured way to manage the business's decline. The result? A sudden closure that left many people jobless overnight. It's a scenario that plays out all too often in our industry, and it's one of the hidden risks that many don't consider when entering the Cannabis market. Rescheduling Cannabis to Schedule III could change this landscape dramatically. Here's what it might mean: 1. *Access to Chapter 11:* Cannabis businesses could gain the ability to file for Chapter 11 bankruptcy protection. This isn't about escaping debts; it's about providing a structured process for reorganization. It gives struggling businesses a chance to restructure their debts, renegotiate contracts, and potentially emerge as viable entities. 2. *Job Preservation:* With the option to reorganize rather than abruptly close, many jobs could be saved. In an industry that's becoming a significant employer in many states, this is crucial for local economies. 3. *Orderly Asset Distribution:* In cases where a business can't be saved, bankruptcy protection ensures a fair and orderly distribution of assets among creditors. This is far preferable to the current situation where the process can be chaotic and inequitable. 4. *Increased Investor Confidence:* The availability of bankruptcy protection could actually encourage more investment in the industry. Investors may be more willing to take risks if they know there's a structured process in place should things go wrong. 5. *Better Long-term Planning:* Cannabis businesses will be able to engage in more robust long-term planning, knowing they have this financial safety net if needed. It's important to note that while bankruptcy protection can be a lifeline, it's not a get-out-of-jail-free card. Businesses will still need to operate responsibly and maintain strong financial controls. As accountants and financial advisors, our role will be to help Cannabis businesses stay financially healthy and to guide them through the bankruptcy process if it becomes necessary. The introduction of bankruptcy protection to the Cannabis industry represents more than just a financial tool – it's a step towards normalizing Cannabis businesses in the eyes of the law and the financial sector. It's another piece of the puzzle in creating a stable, sustainable Cannabis industry that can weather economic ups and downs like any other sector. *Interested in Offering World-Class Accounting Services to the Cannabis Industry? * The Cannabis industry needs trained accountants now more than ever, to help them with compliance and maintaining a profitable, healthy business. We’ll teach you how to provide CFO-level support to growing companies in one of the fastest-growing industries in our generation. Click here to learn more. *Interstate Commerce: Breaking Down State Barriers* One of the most significant changes that rescheduling could bring to the Cannabis industry is the possibility of interstate commerce. This shift has the potential to completely reshape the market landscape. Let me break down what this could mean for the industry. *Current state of affairs * Right now, we essentially have 44 different state markets with varying pricing structures for similar products. It's a fragmented system that leads to inefficiencies and missed opportunities. For example, if you create an exceptional THC-infused kombucha in Oregon, you're limited to selling it within state lines. You can't ship it to Illinois, Oklahoma, or any other state, regardless of demand. This restriction limits growth potential and forces businesses to duplicate efforts across multiple states. *Opening new markets * Imagine a scenario where you could produce Cannabis products in one state and sell them across the entire country. This would allow businesses to: 1. Expand their customer base exponentially 2. Take advantage of economies of scale in production 3. Specialize in products that may have national appeal but limited local demand 4. Reduce costs by centralizing production in areas with optimal growing conditions or lower operating costs For instance, a California edibles manufacturer could suddenly access markets in Florida, New York, and everywhere in between. This opens up enormous growth potential for businesses that are currently constrained by state boundaries. *Challenges of state protectionism * However, it's not going to be a simple free-for-all. We need to be prepared for some pushback and complications: 1. *State-Level Protections:* States that have invested heavily in building up their local Cannabis industries may implement measures to protect these businesses from out-of-state competition. This could manifest as additional taxes on imported Cannabis products or licensing requirements for out-of-state businesses. 2. *Regulatory Disparities:* Different states have varying regulations on things like pesticide use, testing requirements, and product formulations. Navigating these differences for interstate sales will be complex. 3. *Tax Implications:* The current tax structures are based on intrastate commerce. Interstate sales will require new frameworks for how taxes are collected and distributed. 4. *Transportation Challenges:* Transporting Cannabis across state lines will require new security measures and tracking systems to prevent diversion to the black market. *Comparison to Other Industries * We might see a system develop similar to what we have with alcohol distribution. After Prohibition, many states implemented a three-tier system for alcohol sales, and we could see something similar emerge for Cannabis. This could involve separate licenses for producers, distributors, and retailers, with specific rules governing how products move between these tiers across state lines. *Implications for businesses and accountants * For Cannabis businesses, this shift will require: 1. Reevaluating business models and growth strategies 2. Investing in logistics and distribution networks 3. Navigating a more complex regulatory environment As accountants and financial advisors, we'll need to help our clients: 1. Understand the tax implications of selling across state lines 2. Develop systems for tracking multi-state sales and compliance 3. Evaluate opportunities for expansion or partnerships in new markets 4. Manage the increased complexity in financial reporting and auditing The move to interstate commerce represents both a massive opportunity and a significant challenge for the Cannabis industry. It has the potential to create national brands, drive down costs for consumers, and fuel rapid industry growth. However, it will also increase complexity and competition. Businesses that are prepared for this shift – with robust financial systems, clear strategies, and expert advice – will be best positioned to thrive in this new landscape. *Research and Development: Unleashing Innovation* Rescheduling Cannabis to Schedule III has the potential to dramatically accelerate research and development in the industry. This shift could unlock a new era of innovation, bringing together the worlds of Cannabis, pharmaceuticals, and biotechnology. Big pharma's entry into Cannabis One of the most significant changes we're likely to see is the entry of major pharmaceutical companies into the Cannabis space. These companies have been watching from the sidelines, hesitant to engage with a Schedule I substance. With rescheduling, we can expect them to dive in headfirst, bringing with them: 1. *Substantial R&D Budgets:* Pharmaceutical giants have deep pockets for research, potentially dwarfing current Cannabis R&D spending. 2. *Advanced Research Facilities:* Access to state-of-the-art labs and research tools could accelerate discoveries. 3. *Experienced Research Teams:* Scientists with expertise in drug development could bring new perspectives to Cannabis research. *Explosion of New Medicines and Products * This influx of resources and expertise could lead to a boom in new Cannabis-based medicines and products: 1. *Targeted Therapies:* We might see medications developed for specific conditions, moving beyond the current broad-spectrum approach of many Cannabis products. 2. *New Delivery Systems:* Research could yield innovative ways to administer cannabinoids, improving efficacy and patient experience. 3. *Isolating New Compounds:* Beyond THC and CBD, there are hundreds of cannabinoids and terpenes to explore. R&D could unlock the potential of these lesser-known compounds. 4. *Combination Therapies:* We might see Cannabis compounds combined with traditional pharmaceuticals for enhanced effects. Standardization and Quality Control Increased R&D is likely to lead to more standardized products: 1. *Consistent Dosing:* Pharmaceutical-grade products could offer more precise and reliable dosing. 2. *Quality Assurance:* Stricter manufacturing standards could improve product safety and consistency. 3. *Clinical Trials:* More robust clinical trials could provide stronger evidence for Cannabis's medical benefits. *Impact on the Industry * This R&D boom will have far-reaching effects: 1. Intellectual Property: We're likely to see a surge in Cannabis-related patents and proprietary formulations. 2. Job Creation: Increased R&D will create new jobs for scientists, researchers, and support staff. 3. Investment Opportunities: Companies with strong R&D pipelines could become attractive investment targets. *Challenges and Considerations * However, this shift also brings challenges: 1. Regulatory Navigation: Researchers will need to navigate FDA approval processes, which can be lengthy and costly. 2. Balancing Act: The industry will need to balance pharmaceutical development with the needs of existing medical Cannabis patients. 3. Small Players vs. Big Pharma: Smaller Cannabis companies might struggle to compete with the resources of large pharmaceutical corporations. *Implications for Cannabis Professionals * For those of us working in Cannabis finance and accounting, this R&D boom means: 1. New Valuation Metrics: We'll need to consider R&D pipelines and intellectual property in company valuations. 2. Complex Accounting: Tracking R&D expenses and capitalizing on successful developments will become crucial. 3. Funding Strategies: We'll need to help clients navigate funding options for costly R&D projects. 4. Tax Implications: Understanding R&D tax credits and how they apply to Cannabis businesses will be essential. The potential for R&D in a post-rescheduling Cannabis industry is enormous. It promises to transform not just the products available, but the entire landscape of the industry. As financial professionals, we need to be prepared to guide our clients through this new terrain, helping them capitalize on opportunities while navigating the complexities that come with increased research and development. *Regulatory Landscape: Navigating New Waters* Rescheduling Cannabis to Schedule III will significantly alter the regulatory landscape, but it won't simplify it entirely. In fact, we're likely to see a more complex, multi-layered regulatory environment emerge. Here's what we can expect: *Continued state-level regulation* Despite federal rescheduling, states will retain a significant role in Cannabis regulation: 1. Licensing: States will likely continue to control who can grow, process, and sell Cannabis within their borders. 2. Local Control: Many states allow municipalities to ban or restrict Cannabis businesses, a practice that's likely to continue. 3. State-Specific Rules: Expect continued variation in things like possession limits, home cultivation rights, and public consumption laws. This means Cannabis businesses will still need to navigate a patchwork of state regulations, especially if operating across multiple jurisdictions. *Federal oversight expansion * Rescheduling will bring increased federal involvement, primarily through agencies like the FDA and USDA: 1. FDA Oversight: The Food and Drug Administration will likely play a larger role in regulating Cannabis products, especially those making health claims. This could include: - Product safety standards - Labeling requirements - Marketing restrictions - Clinical trial oversight for medical claims 2. USDA Involvement: The U.S. Department of Agriculture may become more involved in setting standards for Cannabis cultivation, potentially including: - Organic certification processes - Pesticide use guidelines - Crop insurance programs 3. Federal Quality Standards: We might see the development of federal Good Manufacturing Practices (GMP) specific to Cannabis, similar to those in the pharmaceutical industry. Taxation Changes The regulatory shift will likely bring changes to the tax landscape: 1. 280E Reform: With Cannabis off Schedule I, we could see the end of 280E's application to Cannabis businesses, allowing for normal business deductions. 2. New Federal Taxes: However, don't be surprised if new federal excise taxes are introduced, similar to those on alcohol and tobacco. 3. State Tax Adjustments: States may need to adjust their tax structures in response to federal changes and to remain competitive with neighboring states. *Banking and financial services regulations * As banking opens up to the Cannabis industry, we'll see new regulatory frameworks emerge: 1. FinCEN Guidelines: Expect updated guidelines from the Financial Crimes Enforcement Network on how banks should work with Cannabis businesses. 2. Federal Reserve Policies: The Federal Reserve may need to create new policies for Cannabis banking, potentially including special reporting requirements. *Consumer Protection * With Cannabis becoming more mainstream, expect an increased focus on consumer protection: 1. Age Restrictions: Federal guidelines on age restrictions for Cannabis purchases may be implemented. 2. Product Testing: More rigorous and standardized testing requirements for potency, contaminants, and consistency. 3. Advertising Restrictions: Similar to tobacco, we might see federal restrictions on how Cannabis products can be advertised. *Environmental Regulations * The Cannabis industry's environmental impact will likely face increased scrutiny: 1. Energy Use: Regulations on energy consumption for indoor growing operations. 2. Water Usage: Guidelines on water use and runoff, especially in drought-prone areas. 3. Packaging Waste: Potential regulations on packaging materials and recycling requirements. *Implications for Cannabis Businesses and Financial Professionals * This evolving regulatory landscape will have significant implications: 1. Compliance Costs: Businesses will need to invest in robust compliance systems to navigate federal and state regulations. 2. Interstate Commerce Complexities: As discussed earlier, regulations around interstate Cannabis commerce will add new layers of complexity. 3. Increased Need for Expertise: Cannabis businesses will rely heavily on legal and financial professionals to navigate this new regulatory environment. 4. Reporting and Auditing: More complex regulations will require more sophisticated financial reporting and auditing processes. As accountants and financial advisors in the Cannabis space, we'll need to: - Stay up-to-date with rapidly changing regulations at both state and federal levels. - Help clients implement systems to ensure compliance across multiple regulatory frameworks. - Advise on the financial implications of new regulations, including tax changes and compliance costs. - Assist in preparing financial statements that meet new federal standards while still addressing state-specific requirements. The post-rescheduling regulatory landscape for Cannabis will be complex and dynamic. While it may resolve some current issues, it will undoubtedly create new challenges. Our role as financial professionals will be crucial in helping Cannabis businesses not just comply with these new regulations, but thrive within them. *Investors, Valuations, and Due Diligence: A New Era of Scrutiny* The rescheduling of Cannabis is set to dramatically alter the investment landscape. Let's dive into what this means for investors, company valuations, and the level of due diligence we can expect to see. *Investor landscape evolution * In the early days of the Cannabis industry, many investors got burned. They jumped in quickly, excited by the potential of this new market, without ensuring proper controls or good books were in place. The result? A lot of lost money and increased wariness among investors. Today's Cannabis investors are much more cautious and demanding. They're looking for businesses that can demonstrate: 1. Solid Financial Controls: Investors want to see that a company has robust systems in place to track and manage its finances accurately. 2. Compliance with Regulations: Given the complex regulatory environment, investors need assurance that businesses are operating within the law. 3. Strong Governance: Clear leadership structures and decision-making processes are crucial. 4. Growth Potential: Investors are looking for businesses that can scale and adapt in this rapidly changing industry. *Perpetual Data Rooms: A New Standard * One of the key demands we're seeing from investors is the implementation of perpetual data rooms. These are digital repositories that contain all crucial business documents and are continuously updated. They include: - Permanent files like leases, insurance policies, and tax returns - Regularly updated financial statements - Bank statements and invoices - What we call a "permanent audit trail" Having a well-maintained perpetual data room signals to investors that a business is organized, transparent, and ready for scrutiny. It's becoming a standard expectation, even for pre-revenue companies. *Valuations: The 280E effect * The potential elimination of 280E (the tax code that prohibits standard business deductions for Cannabis companies) could have a massive impact on valuations. Here's why: 1. Increased Cash Flow: Without 280E, Cannabis businesses could see their cash flow increase by 15-40%, depending on their effective tax rate and location. 2. Higher Net Income: The ability to deduct standard business expenses will significantly boost net income figures. 3. Multiplier Effect: These improvements in financial performance could lead to valuation increases of 5-10x almost overnight. For perspective, imagine a dispensary currently valued at $2 million. If 280E goes away, that same dispensary could potentially be worth $16 million. That's a game-changing increase for owners and investors. *Enhanced due diligence * With higher stakes and more institutional investors potentially entering the market, we can expect to see a much more rigorous due diligence process. This will likely include: 1. *Detailed Financial Audits:* Investors will want to see clean, accurate financial statements that can withstand scrutiny. 2. *Compliance Checks:* Thorough reviews of all licenses, permits, and adherence to state and local regulations. 3. *Operational Assessments:* Deep dives into business operations, supply chains, and growth strategies. 4. *Management Team Evaluation:* Close examination of the experience and track record of key personnel. 5. *Market Analysis:* Detailed assessment of the company's position in the market and growth potential. *Implications for Cannabis businesses * To attract investment and maximize valuations in this new landscape, Cannabis businesses need to: 1. *Implement Robust Financial Systems:* This includes detailed record-keeping, regular financial reporting, and strong internal controls. 2. *Maintain Impeccable Compliance:* Given the industry's regulatory complexities, businesses must be able to demonstrate strict adherence to all applicable laws. 3. *Develop Clear Growth Strategies:* Investors will be looking for well-thought-out plans for scaling and expanding the business. 4. *Build Strong Management Teams:* Having experienced, credible leadership will be crucial for attracting investment. 5. *Prepare for Scrutiny:* Businesses should be ready for a level of due diligence that may be more intense than they've experienced before. *The role of Cannabis Accounting Professionals * As accountants and financial advisors in the Cannabis industry, our role becomes even more critical in this evolving landscape. We need to: 1. Help clients build and maintain those all-important perpetual data rooms. 2. Ensure financial statements are audit-ready at all times. 3. Assist in developing financial models that can withstand investor scrutiny. 4. Guide clients through the complexities of valuation in a post-280E world. 5. Prepare clients for the level of due diligence they can expect from sophisticated investors. Our DOPE CFO Certified Advisors have helped clients raise over $10 million in cash. We know what investors and banks are looking for, and have access to several funding sources that are ready to provide capital. Give your clients the full suite of CFO services that they deserve by becoming a DOPE CFO Certified Advisor today. Click here to learn more. The rescheduling of Cannabis represents a massive opportunity for the industry, potentially unleashing a flood of new investment. However, it also means Cannabis businesses will be held to higher standards than ever before. Those that are prepared – with clean books, strong compliance, and clear growth strategies – will be best positioned to attract investment and achieve favorable valuations in this new era. *Descheduling vs Rescheduling * It’s also important to note that descheduling is different from rescheduling. Descheduling means you take it completely off the schedule. Ideally, that’s what we’ll see happen with Cannabis in the future. It's what happened with hemp and CBD back in 2018. If it comes off the schedules, then it could still be regulated by the state. For example, alcohol is not on schedules one to five and is regulated by the state, and can't be sold to minors. Different states have different laws. You know, in my home state of Oklahoma, you know, you couldn't drink craft brew during my years of growing up. Cannabis rescheduling will result in a lot of changes… But how will those changes affect accountants, bookkeepers, CPAs, and their clients? *How This Will Affect Accountants, Bookkeepers, CPAs, & Our Clients* The rescheduling of Cannabis will bring significant changes to the industry, and these changes will undoubtedly impact the work of accountants, bookkeepers, and CPAs serving Cannabis clients. The good news is that the fundamental principles of GAAP accounting will remain the same. This means that the core accounting practices you've honed will still be applicable, even as the industry undergoes transformation. *Accounting Changes* *280E and complex returns* The good news for us is - whether it's a farm, a processing plant, a manufacturer, a distributor, or a retailer - GAAP accounting is the same. It has nothing to do with the tax code and will remain complex and difficult to navigate. There will still be a need for cost accounting and the industry will still be multi-vertical. Just like every other complex niche in the US that is fully legal, like oil and gas or e-commerce or software, Cannabis will need niche experts to support their accounting. We’re likely to see lots of startups, cap raises, M&A, and exits as restrictions on the industry loosen. Things will heat up really quickly when rescheduling happens. Preparing taxes for Cannabis businesses is set to become more complex with rescheduling. Currently, due to IRC Section 280E, Cannabis businesses can't deduct most ordinary business expenses on their federal tax returns. However, they can include costs directly related to producing or acquiring their product as Cost of Goods Sold (COGS). Determining COGS for Cannabis businesses is already complicated. We must use GAAP cost accounting principles, specifically the rules under IRC Section 471, to calculate COGS accurately. This is crucial because COGS is considered a reduction of gross receipts rather than a deduction, allowing Cannabis businesses to recover some costs despite 280E restrictions. If Cannabis is rescheduled and 280E no longer applies, tax returns will likely become even more intricate. Businesses will need to navigate standard corporate tax rules, including various deductions and credits that were previously unavailable to them. This shift will require a more comprehensive approach to tax planning and preparation, potentially increasing the complexity of Cannabis tax returns. *Rescheduling and the Accountant’s Impact on Cannabis Company Valuations* To illustrate the potential impact of rescheduling on Cannabis company valuations, let's look at some data from leading multi-state operators (MSOs) in the industry. This information, compiled by the Green Market Report, provides a snapshot of current valuations and helps us project how these might change if 280E restrictions are lifted. (Source: Green Market Report) The chart shows various financial metrics for major Cannabis companies, including Enterprise Value (EV) to EBITDA ratios. These ratios are crucial for understanding how the market values these companies relative to their earnings before interest, taxes, depreciation, and amortization. Currently, we see EV/EBITDA ratios for 2023 estimates ranging widely, from as low as 4.57x for Ascend Wellness to as high as 53.10x for Glass House Brands. This wide range reflects the current uncertainty and variability in the Cannabis market. However, if 280E restrictions are removed, we could see a significant boost to these companies' EBITDA figures. Industry analysts, including those at Cannabis Business Executive, suggest we could see valuation multiples increase by a factor of 5 to 10 times current levels. To put this into perspective, let's consider a hypothetical example. If a Cannabis dispensary is currently valued at $2 million, the elimination of 280E could potentially increase its value to $16 million - an 8x increase. This dramatic rise would be driven by the sudden ability to deduct ordinary business expenses, significantly improving profitability and cash flow. This potential for value creation is not just theoretical. It represents real opportunities for business owners, investors, and even employees in the Cannabis industry. It also underscores the critical importance of proper financial management and reporting in the sector. As accountants and financial advisors, our role in helping Cannabis businesses navigate this potential transition and maximize their valuations will be more crucial than ever. *Is it going to be Challenging for Cannabis CFOs?* The road ahead for Cannabis CFOs is undoubtedly challenging. Regardless of whether Cannabis is descheduled or rescheduled, the industry will remain highly complex. CFOs will need to navigate extensive compliance requirements, limitations in vendor services, and the integration of numerous Cannabis-specific software solutions. The industry's rapid growth and evolving regulatory landscape will further compound these challenges. However, these challenges also represent an exciting opportunity for growth and innovation. As the industry matures, we can expect to see the development of more sophisticated accounting tools and industry-specific guidance. The increasing demand for skilled professionals in Cannabis accounting and finance underscores the potential for a rewarding and impactful career in this field. Despite the complexities, the Cannabis industry presents a promising future. Even without federal rescheduling, the industry has experienced massive growth, with states like Ohio and Minnesota recently legalizing Cannabis. The potential for full legalization in Florida and continued growth in states like Michigan and Massachusetts further highlights the industry's upward trajectory. This growth translates into a wealth of opportunities for accountants, CFOs, and CPAs willing to embrace the challenges and complexities of this booming and exciting industry. Our nationally recognized Cannabis accounting program has seen a surge in students eager to tap into these opportunities, even in states where Cannabis remains illegal. This demonstrates the growing recognition of the potential for success in Cannabis accounting and finance, regardless of location. The evolving Cannabis landscape is ripe with possibilities, and those prepared to navigate its complexities will be well-positioned to thrive. < Previous Next > Recent Reviews Bomb Popz Infused Pre-Roll - Fade Co. (Story Dispensary, Waldorf, MD) This Bomb Popz infused pre-roll starts winning before you even open the tube. The name alone is a hit of pure nostalgia. You remember the popsicle - red, white, and blue, chased down the block on a sweltering afternoon, guaranteed to turn your tongue three colors. It made an ordinary summer day feel like a holiday. Fade Co bottled that carefree energy and rolled it into a diamond-infused pre-roll. And the potency backs up the fun: premium indoor flower boosted with THCA diamo Torrone #2 by Savvy - gLeaf (Rockville, Maryland) Cultivated by Savvy and available at gLeaf Dispensary in Rockville, this lovely batch of Torrone #2 is an intriguing introduction to mode... Jokerz by Alt Sol - Green Theory DC This batch of Jokerz, cultivated by Alt Sol and currently available at Green Theory dispensary in Washington DC, is an indica-dominant st... 1 2 3 4 5

Everything about PHD: effects, typical THC, lineage, and terpenes — plus hands-on product reviews and bud photos from Toker's Guide's DMV experts. < Back PHD Strain Review Type Hybrid THC % 16% Dominant Terpene Energy Myrcene Unknown Overview PHD (also known as PhD) is a balanced hybrid marijuana strain known for its functional and clear-headed effects. While it remains a more obscure cultivar in the cannabis market, it is valued by those seeking a "doctor-approved" level of clarity and productivity. Effects PHD is a balanced hybrid strain celebrated for delivering a manageable and uplifting high that enhances focus, creativity, and mood without inducing heavy sedation or "couch-lock." It is an ideal daytime choice for those seeking to maintain high energy levels and productivity while managing ailments such as minor aches, stress, and mental fatigue. The strain's therapeutic profile is driven by a terpene blend featuring pinene, which promotes alertness and a sharp pine aroma; myrcene, which provides herbal notes and gentle physical relaxation; and caryophyllene, which adds a spicy kick and potential anti-inflammatory benefits. This combination makes PHD a sophisticated "workday" strain for users who prioritize mental clarity and functional relief over intense psychoactivity. Positive Effects Side Effects Common Uses Relaxed 0% Happy 0% Euphoric 0% Uplifted 0% Talkative 0% Creative 0% Energetic 0% Focused 0% Giggly 0% Tingly 0% Hungry 0% Sleepy 0% Unknown Dry Mouth 0% Dry Eyes 0% Dizzy 0% Paranoid 0% Anxious 0% Hungry 0% Tingly 0% Sleepy 0% Appearance PHD typically produces dense, spade-shaped forest green buds. These nuggets are often accented by thin, wiry orange hairs and a light dusting of milky white crystal trichomes that give the flower a slightly muted, dusty look. Aroma The scent profile of PHD is predominantly earthy and herbal. Users often note a sharp, medicinal top note reminiscent of pine and eucalyptus, grounded by a deep, musky base that becomes more apparent when the buds are broken apart. Flavor On the palate, PHD offers a clean and crisp experience. The inhale is characterized by savory herbal notes and woody pine, while the exhale leaves a lingering spicy, peppery aftertaste with faint hints of lemon zest. Lineage While its exact genetic heritage is closely guarded by its original breeders, PHD is widely believed to be a cross between a high-CBD landrace and an uplifting sativa-dominant hybrid. This lineage contributes to its reputation as a medicinal-grade strain that avoids heavy sedation. Terpene Profile - Pinene: The most prominent terpene, contributing to the sharp pine aroma and promoting alertness. - Myrcene: Provides the underlying herbal notes and adds a touch of physical relaxation. - Caryophyllene: Adds a spicy kick and may assist with anti-inflammatory benefits.Effects PHD is celebrated for its manageable and uplifting high. It delivers a gentle cerebral buzz that enhances focus, creativity, and mood without inducing anxiety or heavy "couch-lock." It is an ideal daytime strain for managing minor aches, stress, and mental fatigue while remaining fully functional. Cultivation Preferences PHD is considered a resilient strain suitable for intermediate growers. It prefers a controlled indoor environment where humidity can be strictly monitored. - Flowering Time: Approximately 8 to 9 weeks. - Yield: Moderate, favoring quality and cannabinoid consistency over sheer volume. - Maintenance: Responds well to light pruning and low-stress training (LST) to maximize light penetration to lower nodes.Origin The strain originated in the United States, likely emerging from the medical cannabis scenes in either Northern California or the Pacific Northwest, where breeders focused on creating balanced, therapeutic profiles. Seed Suppliers Authentic PHD seeds or clones can be difficult to locate but are occasionally available through specialty boutique nurseries or regional seed banks such as Premium Cultivars or through local Pacific Northwest dispensaries. Conclusion PHD is a sophisticated choice for users who prioritize mental clarity and therapeutic relief over intense psychoactivity. Its balanced nature and clean flavor profile make it a reliable "workday" strain for those looking to stay sharp and pain-free. Previous Next

Colorado Governor Jared Polis is concerned about new federal restrictions on hemp, which ban hemp-derived CBD products with a THC content greater than 0.4 milligrams per package starting in November 2026. The governor criticizes the federal government, specifically Republicans, for leading with fear and potentially stifling the hemp industry's growth and innovation, despite Colorado being a leader in hemp cultivation since 2012. The state already has its own restrictions, defining legal hemp as having no more than 0.3 percent delta-9 THC on a dry weight basis, and currently prohibits the sale of THC products manufactured from hemp, citing health concerns and lack of regulation. < Back Colorado Governor Criticizes GOP for Federal Hemp THC Ban Nov 20, 2025 Source: Marijuana Moment Marijuana Moment Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Colorado Governor Jared Polis is pushing back hard against new federal restrictions that could seriously shake up the hemp world. Tucked into a recent congressional resolution, these rules aim to ban hemp-derived CBD products containing more than 0.4 milligrams of THC per package by late 2026. Polis, a longtime advocate for the plant, argues that this move leads with fear rather than innovation and could crush a flourishing industry that Colorado helped build. While the state already has its own strict guidelines to ensure safety, this federal overreach threatens the livelihoods of farmers and the variety of products available to consumers. For everyday tokers and wellness seekers, this is a big deal because it could wipe out many of the accessible CBD and hemp-based options currently on the shelves. Seeing a high-profile leader like Polis stand up for the industry is encouraging; it highlights the need for sensible, science-based regulations instead of blanket bans that stifle progress and limit community access to the plant’s benefits. < Previous Next > Recent Reviews Bomb Popz Infused Pre-Roll - Fade Co. (Story Dispensary, Waldorf, MD) This Bomb Popz infused pre-roll starts winning before you even open the tube. The name alone is a hit of pure nostalgia. You remember the popsicle - red, white, and blue, chased down the block on a sweltering afternoon, guaranteed to turn your tongue three colors. It made an ordinary summer day feel like a holiday. Fade Co bottled that carefree energy and rolled it into a diamond-infused pre-roll. And the potency backs up the fun: premium indoor flower boosted with THCA diamo Torrone #2 by Savvy - gLeaf (Rockville, Maryland) Cultivated by Savvy and available at gLeaf Dispensary in Rockville, this lovely batch of Torrone #2 is an intriguing introduction to mode... Jokerz by Alt Sol - Green Theory DC This batch of Jokerz, cultivated by Alt Sol and currently available at Green Theory dispensary in Washington DC, is an indica-dominant st... 1 2 3 4 5

Everything about Laughing Buddha: effects, typical THC, lineage, and terpenes — plus hands-on product reviews and bud photos from Toker's Guide's DMV experts. < Back Laughing Buddha Strain Review Type Sativa THC % 20% Dominant Terpene Energy Myrcene Happy, Uplifted Overview Laughing Buddha is a renowned, award-winning sativa-dominant hybrid that earned the prestigious 2003 High Times Cannabis Cup. Developed by Barney's Farm, this strain is celebrated for its invigorating energy and its ability to induce bouts of laughter and joy. Effects Laughing Buddha is a potent sativa-dominant hybrid that delivers a powerful sense of happiness and euphoria, making it highly effective for inducing an upbeat, giggly mood. This strain is particularly well-suited for managing symptoms of stress, fatigue, and depression, providing users with a significant boost in energy levels that is ideal for social gatherings or creative endeavors. Its complex terpene profile is led by myrcene, which provides an earthy base and relaxing undertones; limonene, which contributes sweet citrus notes and mood-elevating properties; and caryophyllene, which adds a spicy kick and offers potential anti-inflammatory benefits. Together, these elements create a predominantly cerebral and energizing experience that leaves consumers feeling joyful and revitalized. Positive Effects Side Effects Common Uses Relaxed 0% Happy 64% Euphoric 48% Uplifted 60% Talkative 0% Creative 0% Energetic 48% Focused 0% Giggly 47% Tingly 0% Hungry 0% Sleepy 0% stress, pain, depression, anxiety, fatigue Dry Mouth 18% Dry Eyes 12% Dizzy 4% Paranoid 4% Anxious 4% Hungry 0% Tingly 0% Sleepy 0% Appearance This strain grows exceptionally tall and fast, characterized by its elongated, oversized colas. At harvest, the plant is nearly covered in full, frosty buds that sparkle with a thick layer of white trichomes against a backdrop of light green foliage and thin orange pistils. Aroma The scent of Laughing Buddha is complex and inviting. It leads with a distinct earthiness followed by a sweet, fruity bouquet. These primary notes are punctuated by sharp hints of spice and a rich, pungent undertone that becomes more apparent once the buds are broken apart. Flavor The smoke is dense and pungent, offering a flavor profile that mirrors its aromatic complexity. Users can expect a delightful mix of sweet tropical fruit and roasted nuts on the inhale, with a savory, spicy, and herbal finish that lingers on the palate. Lineage Laughing Buddha is a potent cross between an indigenous Thai sativa and a Jamaican sativa landrace. This combination of island and southeast Asian genetics results in a classic sativa structure and high-energy cerebral effects. Terpene Profile - Myrcene: Contributes to the earthy base and enhances the strain's relaxing undertones. - Limonene: Provides the sweet, citrusy notes and helps elevate the mood. - Caryophyllene: Adds a spicy, peppery kick and offers potential anti-inflammatory benefits.Effects True to its name, this strain delivers a powerful sense of happiness and euphoria. It is highly effective at promoting an upbeat, giggly mood, making it a favorite for social gatherings or for those looking to manage symptoms of stress and fatigue. The high is predominantly cerebral and energizing. Cultivation Preferences Growing Laughing Buddha requires some patience and skill. It has a relatively long flowering time of approximately 70 to 75 days. - Growth Habit: Because it grows so tall, it requires significant vertical space and regular pruning to manage its size. - Support: The heavy, dense colas often need extra support or trellising to prevent the branches from bending or snapping. - Yield: It is a high-yielding strain, rewarding the extra maintenance with an abundant harvest of resinous flowers.Origin The strain was created in the Netherlands by the expert breeders at Barney's Farm, utilizing landrace genetics sourced from Thailand and Jamaica. Seed Suppliers Authentic Laughing Buddha seeds can be sourced through Barney's Farm, along with major retailers such as Seedsman, MSNL, and North Atlantic Seed Co. Conclusion Laughing Buddha remains a staple for sativa enthusiasts who appreciate the characteristics of landrace-derived hybrids. Its combination of exotic flavors and profound mood-enhancing effects makes it a top-tier choice for experienced users seeking a potent and happy experience. Previous Next

Everything about Gelateria: effects, typical THC, lineage, and terpenes — plus hands-on product reviews and bud photos from Toker's Guide's DMV experts. < Back Gelateria Strain Review Type Hybrid THC % 19% Dominant Terpene Energy Myrcene Unknown Overview Gelateria is a sophisticated hybrid cannabis strain celebrated for its dessert-like aromatic profile and balanced effects. It is a cross that brings together the best of the Gelato lineage, offering a potent and flavorful experience for enthusiasts and medical users alike. Effects Gelateria is a balanced hybrid strain known for delivering a fast-acting cerebral high that boosts creativity and improves mood, making it ideal for social or afternoon use. As the experience progresses, it settles into a soothing body relaxation that relieves tension without causing immediate couch-lock, providing a versatile energy level that transitions from uplifting to calming. This strain is particularly effective for those seeking relief from stress, anxiety, and minor physical aches or muscle tension. Its complex terpene profile is led by limonene, which contributes to its mood-elevating properties and bright citrus scent; caryophyllene, which offers anti-inflammatory benefits and a spicy kick; and myrcene, which enhances physical relaxation with its earthy, herbal base. Together, these elements make Gelateria an exceptional choice for both recreational enjoyment and therapeutic relief. Positive Effects Side Effects Common Uses Relaxed 0% Happy 0% Euphoric 0% Uplifted 0% Talkative 0% Creative 0% Energetic 0% Focused 0% Giggly 0% Tingly 0% Hungry 0% Sleepy 0% Unknown Dry Mouth 0% Dry Eyes 0% Dizzy 0% Paranoid 0% Anxious 0% Hungry 0% Tingly 0% Sleepy 0% Appearance The buds are typically dense and medium-sized, showcasing a palette of deep forest greens and vibrant purple undertones. They are accented by bright orange pistils and a shimmering layer of milky white trichomes that give the flowers a frosty, crystalline look. Aroma It features a pungent and sweet fragrance characterized by notes of creamy vanilla and ripe berries. This sweetness is underpinned by a sharp, fuel-like gas and earthy musk, creating a multi-layered olfactory experience. Flavor On the palate, Gelateria delivers a smooth, sugary taste reminiscent of gourmet ice cream. Users often report distinct flavors of sweet citrus and lavender on the inhale, followed by a woody, slightly spicy finish on the exhale. Lineage This strain is a cross between Gelato \#41 and Sunset Sherbet, though some versions are bred from Gelato \#33 and Soufflé. This genetic heritage results in a balanced hybrid that captures the creamy terpene profiles of its ancestors. Terpene Profile - Limonene: Provides a bright citrus scent and contributes to mood-elevating properties. - Caryophyllene: Adds a spicy, peppery kick and may offer anti-inflammatory benefits. - Myrcene: Contributes to the herbal, earthy base and enhances physical relaxation.Effects Gelateria is known for a fast-acting cerebral high that boosts creativity and improves mood. As the high progresses, it settles into a soothing body relaxation that relieves tension without causing immediate couch-lock, making it suitable for social or afternoon use. Cultivation Preferences It grows well both indoors and outdoors, preferring a controlled, temperate climate with consistent humidity levels. - Flowering Time: Approximately 56 to 63 days. - Yield: Moderate to high, depending on growing conditions and technique. - Maintenance: The plants benefit from topping and low-stress training to manage their bushy growth and improve light penetration.Origin The strain originated in the United States, emerging from the specialized breeding projects of the West Coast cannabis scene, particularly California. Seed Suppliers Authentic genetics and variations can be sourced from suppliers such as Elev8 Seeds, Neptune Seed Bank, and various boutique seed distributors. Conclusion Gelateria is an exceptional choice for those seeking a complex flavor profile and a versatile, balanced high. Its blend of uplifting mental energy and physical calm makes it a standout hybrid that appeals to both recreational users and those seeking relief from stress or minor aches. Previous Next

Everything about Bonzai: effects, typical THC, lineage, and terpenes — plus hands-on product reviews and bud photos from Toker's Guide's DMV experts. < Back Bonzai Strain Review Type Hybrid THC % 18% Dominant Terpene Energy NA Unknown Overview Bonzai is a versatile hybrid strain renowned for its balanced profile and potent therapeutic potential. Often bred from the lineage of Qrazy Train and Purple Punch, it is celebrated for delivering a harmonious blend of cerebral euphoria and deep physical relaxation, making it a popular choice for both recreational enjoyment and medicinal relief. Effects Bonzai is a balanced hybrid strain that delivers a fast-acting, lifted sensation, boosting focus, creativity, and happiness before transitioning into a creeping body lock that provides deep physical relaxation. This versatile profile makes it an excellent choice for managing ailments such as chronic fatigue, depression, stress, anxiety, and minor physical pain. Its energy levels begin with a euphoric rush and settle into a functional yet powerful high that is not immediately overwhelming. The strain's complex effects are driven by a rich terpene profile led by Linalool, which offers calming and anti-anxiety benefits; Beta-Caryophyllene, which provides anti-inflammatory and pain-relief properties; Limonene, which aids in mood elevation; and Myrcene, which promotes physical sedation. Positive Effects Side Effects Common Uses Relaxed 0% Happy 0% Euphoric 0% Uplifted 0% Talkative 0% Creative 0% Energetic 0% Focused 0% Giggly 0% Tingly 0% Hungry 0% Sleepy 0% Unknown Dry Mouth 0% Dry Eyes 0% Dizzy 0% Paranoid 0% Anxious 0% Hungry 0% Tingly 0% Sleepy 0% Appearance The buds of Bonzai are typically oversized and pepper-shaped with an olive-green base. They frequently exhibit vibrant purple undertones and are adorned with thin orange pistils. A thick, frosty coating of white crystal trichomes gives the nugs a shimmering, resinous finish. Aroma The scent profile is complex and inviting, featuring prominent woody pine overtones. This earthy base is layered with the fragrance of sweet forest fruits, ripe peaches, and subtle hints of spice, creating a pungent yet refreshing bouquet. Flavor On the inhale, users experience a burst of sweet blueberry and berry flavors. The exhale is characterized by smooth tree fruit notes and a lingering piney aftertaste, offering a well-rounded and flavorful smoking or vaping experience. Lineage The most common version of Bonzai is a balanced hybrid (50% indica/50% sativa) created by crossing Qrazy Train and Purple Punch. Another notable phenotype involves a cross of Kaizen and Zikigai, focusing on Zkittlez-dominant traits. Terpene Profile - Linalool: The dominant terpene, providing a floral aroma and significant calming, anti-anxiety effects. - Beta-Caryophyllene: Adds spicy notes and offers potential anti-inflammatory and pain-relief benefits. - Limonene: Contributes a citrus brightness and aids in mood elevation and stress reduction. - Myrcene: Enhances the earthy scent and promotes physical relaxation and sedation.Effects Bonzai delivers a fast-acting "lifted" sensation that boosts focus, creativity, and happiness. This initial euphoric rush eventually transitions into a creeping body lock, providing deep relaxation without being immediately overwhelming. It is frequently used to manage chronic fatigue, depression, stress, anxiety, and minor physical pain. Cultivation Preferences - Flowering Time: Approximately 8 to 9 weeks (55–65 days). - Yield: High, especially in controlled indoor environments. - Climate: Thrives in warm, sunny environments but is resilient enough for outdoor growth, typically ready for harvest by mid-October. It responds well to training techniques like SCROG to manage its medium stature.Origin Modern versions of this strain were developed by breeders such as Pete's Farmstand and Raw Genetics, with roots in the American West Coast breeding scene, particularly focusing on crossing potent "new-school" fruit hybrids with established heavy hitters. Seed Suppliers Authentic seeds or clones can be sourced through specialized providers such as Raw Genetics, Perfect Tree (for the Banzai variant), and various licensed retailers in the New Jersey and California markets. Conclusion Bonzai stands out as a top-tier choice for those seeking a functional yet powerful high. Its exceptional terpene profile and striking visual appeal make it a favorite for connoisseurs who value both flavor and a balanced, long-lasting effect. Previous Next

Everything about Hawaiian Delight: effects, typical THC, lineage, and terpenes — plus hands-on product reviews and bud photos from Toker's Guide's DMV experts. < Back Hawaiian Delight Strain Review Type Indica THC % 19% Dominant Terpene Energy NA Relaxed, Happy Overview Hawaiian Delight is a tropical-themed hybrid strain known for its relaxing properties and sensory appeal. It is often sought after for its smooth, dessert-like qualities and balanced effects. Effects Hawaiian Delight is an indica-dominant hybrid primarily known for its calming and euphoric effects, providing a gentle cerebral lift that transitions into a deep, soothing body stone. It is highly effective for evening use or low-energy activities, helping users manage stress, anxiety, and mild physical discomfort without causing immediate heavy sedation. The strain’s terpene profile is led by myrcene, which contributes to its musky aroma and sedative properties; pinene, which adds a fresh pine scent and helps sharpen focus; and caryophyllene, which provides a spicy kick along with potential anti-inflammatory benefits. Together, these characteristics make Hawaiian Delight an excellent choice for those seeking classic "island" relaxation and relief from daily stressors. Positive Effects Side Effects Common Uses Relaxed 54% Happy 54% Euphoric 45% Uplifted 36% Talkative 0% Creative 0% Energetic 0% Focused 0% Giggly 0% Tingly 27% Hungry 0% Sleepy 0% stress, pain, depression, anxiety, headache, fatigue Dry Mouth 36% Dry Eyes 9% Dizzy 0% Paranoid 9% Anxious 0% Hungry 0% Tingly 27% Sleepy 0% Appearance The buds of Hawaiian Delight are typically dense and medium-sized, featuring a vibrant light green hue. They are often covered in a generous layer of sticky white trichomes and accented by bright orange pistils, giving the flower a frosted, colorful look. Aroma This strain is characterized by a strong and musky aroma. It carries deep, pungent notes of damp earth and tropical musk, creating a heavy scent profile that is both savory and sweet. Flavor On the palate, Hawaiian Delight offers a complex profile. The inhale is smooth and sweet, while the exhale features a distinct hashy finish. It leaves a pleasant, lingering aftertaste that blends tropical fruitiness with spicy, herbal undertones. Lineage Hawaiian Delight is a three-way cross between Hawaiian, Skunk \#1, and Northern Lights. This genetic combination results in an indica-dominant hybrid that inherits the tropical flair of Hawaiian genetics and the potent, resinous structure of its Skunk and Northern Lights ancestors. Terpene Profile - Myrcene: The dominant terpene, contributing to the strain's musky scent and sedative properties. - Pinene: Adds a touch of fresh pine and sharpens focus. - Caryophyllene: Provides a spicy, peppery kick and potential anti-inflammatory benefits.Effects Hawaiian Delight is primarily known for its calming and euphoric effects. It provides a gentle cerebral lift that transitions into a deep, soothing body stone. It is highly effective for evening use, helping users manage stress, anxiety, and mild physical discomfort without immediate heavy sedation. Cultivation Preferences This strain is generally considered easy to moderate to grow. It prefers a warm, sunny climate similar to its namesake. - Flowering Time: Approximately 8 to 9 weeks. - Yield: Moderate to high, performing well both indoors and in greenhouse environments. - Growth Habit: It tends to stay relatively bushy and manageable in height.Origin As its name suggests, the strain has deep roots in Hawaiian landrace genetics, though it was refined and stabilized by breeders in the Netherlands to incorporate the Skunk and Northern Lights influences. Seed Suppliers Authentic seeds or clones for Hawaiian Delight can often be found through specialized Dutch seed banks like Sensi Seeds or various North American craft breeders who focus on heirloom and tropical hybrids. Conclusion Hawaiian Delight is an excellent choice for those seeking a flavorful, musky strain that delivers a classic "island" relaxation. Its rich lineage and pleasant finish make it a favorite for hybrid lovers who enjoy a balanced, tropical experience. Previous Next

Meet the music and cannabis pioneer behind the Upper East Side's hottest new dispensary. The post Buddha Chief raises vibrations at new Housing Works dispensary in NoMad appeared first on Leafly. < Back Buddha Chief raises vibrations at new Housing Works dispensary in NoMad Mar 4, 2025 Source: Amelia Williams Leafly Article Link Facebook X (Twitter) WhatsApp LinkedIn Pinterest Copy link Meet the music and cannabis pioneer behind the Upper East Side's hottest new dispensary. The post Buddha Chief raises vibrations at new Housing Works dispensary in NoMad appeared first on Leafly. < Previous Next > Recent Reviews Bomb Popz Infused Pre-Roll - Fade Co. (Story Dispensary, Waldorf, MD) This Bomb Popz infused pre-roll starts winning before you even open the tube. The name alone is a hit of pure nostalgia. You remember the popsicle - red, white, and blue, chased down the block on a sweltering afternoon, guaranteed to turn your tongue three colors. It made an ordinary summer day feel like a holiday. Fade Co bottled that carefree energy and rolled it into a diamond-infused pre-roll. And the potency backs up the fun: premium indoor flower boosted with THCA diamo Torrone #2 by Savvy - gLeaf (Rockville, Maryland) Cultivated by Savvy and available at gLeaf Dispensary in Rockville, this lovely batch of Torrone #2 is an intriguing introduction to mode... Jokerz by Alt Sol - Green Theory DC This batch of Jokerz, cultivated by Alt Sol and currently available at Green Theory dispensary in Washington DC, is an indica-dominant st... 1 2 3 4 5